Skip to Main Content

Author Details

James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
1985
156
60
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36711964Functional genomic analysis of adult and pediatric brain tumor isolates.bioRxiv2023
37603953Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.Neoplasia2023
34935967Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).Neuro Oncol2022
35584229Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager.Sci Transl Med2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36136600CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.J Clin Invest2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35157764Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.Neuro Oncol2022
34882234Carboplatin During Craniospinal Radiotherapy for Children With Group 3 Medulloblastoma-A New Standard of Care?-Reply.JAMA Oncol2022
34907396Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.Nat Neurosci2022
33130903Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.Neuro Oncol2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33495505In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli.Sci Rep2021
34885074Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies.Cancers (Basel)2021
34613581Predictors of mortality and tumor recurrence in desmoplastic infantile ganglioglioma and astrocytoma-and individual participant data meta-analysis (IPDMA).J Neurooncol2021
34401600A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.Contemp Clin Trials Commun2021
33963961Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.J Neurooncol2021
34154646Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.Genome Med2021
34292305Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA Oncol2021
31625107Mammalian Surface Display Screening of Diverse Cystine-Dense Peptide Libraries for Difficult-to-Drug Targets.Methods Mol Biol2020
33768215A Protocol for the Generation of Treatment-naïve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models.J Exp Neurol2020
32014389Miniproteins as a Powerful Modality in Drug Development.Trends Biochem Sci2020
33046443Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.Cancer Res2020
32743560Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.Cell Rep Med2020
32902381Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.Elife2020
32304700A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules.J Mol Biol2020
32512236Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria.J Glob Antimicrob Resist2020
32132215A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure.Sci Transl Med2020
32424282Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.Nat Neurosci2020
31160565Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.Nat Commun2019
31664194Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.Nature2019
31208323Laboratory information management software for engineered mini-protein therapeutic workflow.BMC Bioinformatics2019
30892059Simultaneous extraction and analysis of multiple cystine-dense peptides by μSPE and microflow-MS/MS from plasma.Bioanalysis2019
29277756Pacifastin-derived Peptides Target Tumors for Use in <i>In Vivo</i> Imaging.Anticancer Res2018
30006355Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations.Mol Cancer Res2018
30577869Automated in situ chromatin profiling efficiently resolves cell types and gene regulatory programs.Epigenetics Chromatin2018
30349086A biobank of patient-derived pediatric brain tumor models.Nat Med2018
30332335Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.J Clin Oncol2018
29588544Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.Leukemia2018
29523778Publisher Correction: Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets.Nat Commun2018
29717260A modified gene trap approach for improved high-throughput cancer drug discovery.Oncogene2018
29483648Screening, large-scale production and structure-based classification of cystine-dense peptides.Nat Struct Mol Biol2018
28609654Intertumoral Heterogeneity within Medulloblastoma Subgroups.Cancer Cell2017
28364003Multidrug Analyses in Patients Distinguish Efficacious Cancer Agents Based on Both Tumor Cell Killing and Immunomodulation.Cancer Res2017
28167297Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis.Neoplasia2017
28403743Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent.Int J Toxicol2017
29269835Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets.Nat Commun2017
29092942PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.Cancer Res2017
28596487ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.Oncotarget2017
28637687Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models.Clin Cancer Res2017
  • 1 - 50 of 156

Recommended Authors

Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 17
Duane G Currier
St. Jude Children's Research Hospital
Career Start Year 2008
Number of shared co-authors 6
Elizabeth Stewart
St Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 12
Chitra Venugopal
McMaster Stem Cell and Cancer Research Institute
Career Start Year 2006
Number of shared co-authors 20
Annette Bakker
Children's Tumor Foundation
Career Start Year 2004
Number of shared co-authors 2
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 19
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 10
Ping Guo
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year 2001
Number of shared co-authors 1
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 74
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Career Start Year 1998
Number of shared co-authors 53
Ian D Clarke
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 51
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 0
Deborah Lawson
Oncology R&D
Career Start Year 1996
Number of shared co-authors 1
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 29
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 6
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 8
Brian Vaillant
Dell Medical School, University of Texas at Austin
Career Start Year 1995
Number of shared co-authors 9
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 26
Nadia Dahmane
Weill Cornell Medical College
Career Start Year 1994
Number of shared co-authors 2
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1993
Number of shared co-authors 100
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 38
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 15
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year 1990
Number of shared co-authors 4
Abdel G Elkahloun
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 7
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1989
Number of shared co-authors 43
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 9
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 2
John M Maris
Children's Hospital of Philadelphia
Career Start Year 1985
Number of shared co-authors 53
Anna Lasorella
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1984
Number of shared co-authors 18
Charles Keller
Children's Cancer Therapy Development Institute
Career Start Year 1980
Number of shared co-authors 10

Collaborators

Michael D Taylor
The Hospital for Sick Children
Co-authored papers 16
Charles Kooperberg
Co-authored papers 15
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 13
Sarah E S Leary
Co-authored papers 13
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers 12
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers 12
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 12
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 12
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 11
William A Weiss
University of California san francisco
Co-authored papers 10
Richard G Ellenbogen
Seattle Children's Hospital
Co-authored papers 10
Anca Sorana Morrissy
Cumming School of Medicine, University of Calgary
Co-authored papers 10
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 10
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers 10
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 9
David W Ellison
St. Jude Children's Research Hospital
Co-authored papers 9
Wies??awa Grajkowska
Children's Memorial Health Institute
Co-authored papers 9
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 9
Maryam Fouladi
Co-authored papers 9
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 9
Mi-Youn Brusniak
Co-authored papers 8
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers 8
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 8
Roger J Packer
Brain Tumor Institute, Children's National Hospital
Co-authored papers 8
Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers 8
Seung-Ki Kim
Seoul National University Children's Hospital
Co-authored papers 8
Betty Luu
University of Wollongong
Co-authored papers 8
Pim J French
Erasmus MC Cancer Institute
Co-authored papers 8
Toshihiro Kumabe
Kitasato University School of Medicine
Co-authored papers 8
Ruth Luthi-Carter
University of Leicester
Co-authored papers 8
Release 1.2